Marks Group Wealth Management, Inc Astrazeneca PLC Transaction History
Marks Group Wealth Management, Inc
- $967 Million
- Q4 2024
A detailed history of Marks Group Wealth Management, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 44,952 shares of AZN stock, worth $3.3 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
44,952
Previous 43,672
2.93%
Holding current value
$3.3 Million
Previous $3.4 Million
13.43%
% of portfolio
0.3%
Previous 0.34%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.01 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.43 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...